| AML | Acute myeloid leukemia |
| AP-MS | Affinity purification mass spectrometry |
| CDK2AP1 | Cyclin-dependent kinase 2-associated protein 1 |
| CFDA | Chinese Food and Drug Administration |
| CHD | Chromodomain helicase DNA‑binding protein |
| CNS | Central nervous system |
| CoREST | Corepressor of RE1-silencing transcription |
| Cryo-EM | Cryo-electron microscopy |
| DLBCL | Diffuse large B-cell lymphoma |
| DNTTIP1 | Deoxynucleotidyl-transferase terminal-interacting protein 1 |
| EM | Electron microscopy |
| FDA | Food and Drug Administration |
| GPS | G-protein pathway suppressor |
| HDAC | Histone deacetylase |
| HDX-MS | Hydrogen-deuterium exchange MS |
| HL | Hodgkin lymphoma |
| Hsp90 | heat shock protein 90 |
| LSD | Lysine-specific demethylase |
| MBD | Methylated CpG-binding domain protein |
| MiDAC | Mitotic deacetylase |
| MIDEAS | Mitotic deacetylase-associated SANT domain |
| MTA | Metastasis tumor-associated protein |
| NCoR | Nuclear receptor corepressor |
| NMPA | National Medical Products Administration |
| NMR | Nuclear magnetic resonance |
| NuRD | Nucleosome remodeling and deacetylase |
| PTMs | Post-translational modifications |
| QM/MM | Quantum mechanical/molecular mechanical |
| RBBP | Retinoblastoma-binding protein |
| SAHA | Suberoylanilide hydroxamic acid |
| SAP30 | Sin3-associated protein p30 |
| SAXS | Small-angle X-ray scattering |
| Sin3 | Switch intensive 3 |
| SIRT | Sirtuin |
| SMRT | Silencing mediator of retinoic acid and thyroid hormone receptors |
| STAT3 | Signal transducers and activators of transcription 3 |
| SUD3 | Suppressor of defective silencing 3 |
| TBL1 | Transducin beta-like 1 |
| XL-MS | Chemical crosslinking mass spectrometry |
| ZBG | Zinc binding group |